Goldman Sachs BDC Reports Sharp H1 Earnings Decline, Rising Non-Accruals, and Co-CEO Resignation
GSBD is trading near its 52-week low of $8.355 (9.8% above the low).
Summary
Goldman Sachs BDC reported a sharp decline in H1 2026 earnings and NAV, alongside a significant increase in non-accrual investments and the upcoming resignation of Co-CEO David Miller.
Key Events · Earnings and Guidance · GSBD
-
Sharp Decline in H1 Earnings & NAV
Diluted earnings per share (EPS) for the six months ended June 30, 2026, dropped significantly to $0.09, down from $0.60 in the prior year period. Net Asset Value (NAV) per share also decreased to $12.06 as of June 30, 2026, from $12.64 at December 31, 2025.
-
Significant Deterioration in Asset Quality
Non-accrual investments increased substantially to 5.0% of total investments at amortized cost as of June 30, 2026, up from 2.8% at December 31, 2025.
-
Co-CEO David Miller to Resign
Co-Chief Executive Officer and Co-Principal Executive Officer David Miller announced his resignation, effective December 31, 2026. Vivek Bantwal will become the sole CEO and Principal Executive Officer.
-
New Executive Appointment
Justin Betzen was appointed Co-President and Co-Chief Operating Officer, effective August 3, 2026, joining Tucker Greene in the role.
Analysis · GSBD · Unknown
Goldman Sachs BDC, Inc. reported a significant deterioration in its financial performance for the first half of 2026, with diluted EPS plummeting by 85% and a notable decline in Net Asset Value per share. A key concern is the substantial increase in non-accrual investments, indicating a worsening in asset quality. The announcement of Co-Chief Executive Officer David Miller's resignation adds to the executive changes during this challenging period. While the company maintained its base dividend and approved a new share repurchase program, the overall financial results and asset quality trends are strongly negative.
At the time of this filing, GSBD was trading at $9.17 on NYSE in the Unknown sector, with a market capitalization of approximately $1B. The 52-week trading range was $8.36 to $11.62. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.